The Compressed SENSE MRI technique can reduce scan time by more than half without impacting image quality or diagnostic certainty.
Radiology practices can cut the time it takes to conduct knee MRI scans by roughly half with a new protocol that does not create any negative impacts on image quality or diagnostic certainty.
By using Compressed SENSE (CS) to truncate 2D and 3D fat-saturated sequences of the knee, investigators from the University Hospital of Cologne in Germany succeeded in reducing exam times. Doing so can potentially help practices control their costs and improve their throughput. they said.
The team, led by Andra-Iza Iuga, a radiology resident doctor at the University Hospital, published their findings in the Sept. 10 European Journal of Radiology. Specifically, they reported that, when the technique was employed, scan times for 2D knee MRIs dropped by 34.39 percent, and 3D exam times fell by 54.17 percent.
Related Content: New MRI Approach Helps Assess Knee Osteoarthritis Progression
These results clearly show, the team said, that using CS acceleration offers faster exams while leaving image quality and diagnostic certainty untouched. It also offers other benefits for the patient.
“Optimization of scan times not only increases patient’s comfort and decreases the vulnerability of motion artifact,” the team explained, “but it also represents a key factor for cost reduction of MRI exams as it reduces the fixed costs per examination.”
As a technique, CS takes less time because it gathers less sample data for each pixel. To determine how well the technique actually works, Iuga’s team recruited 20 healthy volunteers to test it with a 3T scanner. Each patient underwent a standard protocol MRI, as well as additional scans that used a variety of accelerating factors. Three independent readers examined and rated the images for signal-to-noise, contrast-to-noise, root-mean-square error, and structural similarity index.
According to their analysis, the team determined scan times decreased with an increasing CS factor. Based on their results, the 2D standard sequences was rated the best for diagnostic certainty and overall image impression.
While these findings point to CS efficacy, the team said, additional work is needed.
“Future investigations should consider larger samples sizes and use patients to analyze different knee pathologies and transferability to clinical routine,” they said.
Meta-Analysis Shows No Difference Between bpMRI and mpMRI in Ruling Out csPCa
March 6th 2025In an 18-study meta-analysis involving over 4,600 patients, researchers found that bpMRI and mpMRI had equivalent pooled negative predictive value (NPV) of 92 percent for clinically significant prostate cancer (csPCa).
Is MRI Contrast Enhancement Necessary for Long-Term Monitoring of Diffuse Glioma?
March 4th 2025In a comparison of contrast-enhanced T1-weighted (CET1w) MRI (and T2-weighted MRI/FLAIR imaging, researchers found that only three out of 82 cases of glioma progression were solely detected with CET1w MRI.
Can Deep Learning Ultra-Fast bpMRI Have an Impact in Prostate Cancer Imaging?
March 3rd 2025A deep learning-enhanced ultra-fast bpMRI protocol offered similar sensitivity for csPCa as mpMRI with an 80 percent reduction in scan time, according to research findings presented at the European Congress of Radiology (ECR) conference.